270 related articles for article (PubMed ID: 1332772)
1. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
[TBL] [Abstract][Full Text] [Related]
2. Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin.
King VF; Garcia ML; Himmel D; Reuben JP; Lam YK; Pan JX; Han GQ; Kaczorowski GJ
J Biol Chem; 1988 Feb; 263(5):2238-44. PubMed ID: 2448307
[TBL] [Abstract][Full Text] [Related]
3. Substituted diphenylbutylpiperidines bind to a unique high affinity site on the L-type calcium channel. Evidence for a fourth site in the cardiac calcium entry blocker receptor complex.
King VF; Garcia ML; Shevell JL; Slaughter RS; Kaczorowski GJ
J Biol Chem; 1989 Apr; 264(10):5633-41. PubMed ID: 2538426
[TBL] [Abstract][Full Text] [Related]
4. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
5. Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity.
Garcia ML; King VF; Shevell JL; Slaughter RS; Suarez-Kurtz G; Winquist RJ; Kaczorowski GJ
J Biol Chem; 1990 Mar; 265(7):3763-71. PubMed ID: 2154487
[TBL] [Abstract][Full Text] [Related]
6. Allosteric interaction of semotiadil fumarate, a novel benzothiazine, with 1,4-dihydropyridines, phenylalkylamines, and 1,5-benzothiazepines at the Ca(2+)-channel antagonist binding sites in canine skeletal muscle membranes.
Nakayama K; Nozawa Y; Fukuta Y
J Cardiovasc Pharmacol; 1994 May; 23(5):731-40. PubMed ID: 7521455
[TBL] [Abstract][Full Text] [Related]
7. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
8. A light stabilizer (Tinuvin 770) that elutes from polypropylene plastic tubes is a potent L-type Ca(2+)-channel blocker.
Glossmann H; Hering S; Savchenko A; Berger W; Friedrich K; Garcia ML; Goetz MA; Liesch JM; Zink DL; Kaczorowski GJ
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9523-7. PubMed ID: 8415734
[TBL] [Abstract][Full Text] [Related]
9. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca2+ channels.
Kanda S; Adachi-Akahane S; Nagao T
Eur J Pharmacol; 1998 Oct; 358(3):277-87. PubMed ID: 9822895
[TBL] [Abstract][Full Text] [Related]
11. Dihydropyridine binding and Ca(2+)-channel characterization in clonal calcitonin-secreting cells.
Krautwurst D; Scherübl H; Kleppisch T; Hescheler J; Schultz G
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):659-65. PubMed ID: 8382045
[TBL] [Abstract][Full Text] [Related]
12. Effects of four diltiazem stereoisomers on binding of d-cis-[3H]diltiazem and (+)-[3H]PN200-110 to rabbit T-tubule calcium channels.
Ikeda S; Oka J; Nagao T
Eur J Pharmacol; 1991 Nov; 208(3):199-205. PubMed ID: 1663043
[TBL] [Abstract][Full Text] [Related]
13. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
14. A novel high affinity class of Ca2+ channel blockers.
Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
[TBL] [Abstract][Full Text] [Related]
15. Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit.
Mitterdorfer J; Sinnegger MJ; Grabner M; Striessnig J; Glossmann H
Biochemistry; 1995 Jul; 34(29):9350-5. PubMed ID: 7626604
[TBL] [Abstract][Full Text] [Related]
16. Tetrandrine: a new ligand to block voltage-dependent Ca2+ and Ca(+)-activated K+ channels.
Wang G; Lemos JR
Life Sci; 1995; 56(5):295-306. PubMed ID: 7837929
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of diltiazem interaction with L-type Ca2+ channels.
Kraus RL; Hering S; Grabner M; Ostler D; Striessnig J
J Biol Chem; 1998 Oct; 273(42):27205-12. PubMed ID: 9765241
[TBL] [Abstract][Full Text] [Related]
18. Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel.
Shimasue K; Urushidani T; Hagiwara M; Nagao T
Eur J Pharmacol; 1996 Feb; 296(3):347-50. PubMed ID: 8904088
[TBL] [Abstract][Full Text] [Related]
19. Calciseptine binding to a 1,4-dihydropyridine recognition site of the L-type calcium channel of rat synaptosomal membranes.
Yasuda O; Morimoto S; Chen Y; Jiang B; Kimura T; Sakakibara S; Koh E; Fukuo K; Kitano S; Ogihara T
Biochem Biophys Res Commun; 1993 Jul; 194(2):587-94. PubMed ID: 8393668
[TBL] [Abstract][Full Text] [Related]
20. Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels.
Siegl PK; Garcia ML; King VF; Scott AL; Morgan G; Kaczorowski GJ
Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):684-91. PubMed ID: 2854216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
